会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • POLYMORPHISMS IN THE HUMAN GENES FOR OCT1 AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
    • OCT1基因多态性及其在诊断和治疗应用中的应用
    • WO2004018512A3
    • 2004-07-01
    • PCT/EP0309356
    • 2003-08-22
    • EPIDAUROS BIOTECHNOLOGIE AGKERB REINHOLDKOEPSELL HERMANNBRINKMANN ULRICH
    • KERB REINHOLDKOEPSELL HERMANNBRINKMANN ULRICH
    • A01K67/027A61K38/00A61K38/17A61K48/00C07K14/47C07K16/18C12N15/12C12Q1/68G01N33/50G01N33/53
    • C07K14/4702A01K2217/05A61K38/00C12Q1/6883
    • The present invention relates to a polymorphic OCT1 polynucleotide. Moreover, the invention relates to genes or vectors comprising the polynucleotides of the invention and to a host cell genetically engineered with the polynucleotide or gene of the invention. Further, the invention relates to methods for producing molecular variant polypeptides or fragments thereof, methods for producing cells capable of expressing a molecular variant polypeptide and to a polypeptide or fragment thereof encoded by the polynucleotide or the gene of the invention or which is obtainable by the method or from the cells produced by the method of the invention. Furthermore, the invention relates to an antibody which binds specifically the polypeptide of the invention. Moreover, the invention relates to a transgenic non-human animal. The invention also relates to a solid support comprising one or a plurality of the above mentioned polynucleotides, genes, vectors, polypeptides, antibodies or host cells. Furthermore, methods of identifying a polymorphism, identifying and obtaining a pro-drug or drug or an inhibitor are also encompassed by the present invention. In addition, the invention relates to methods for producing of a pharmaceutical composition and to methods of diagnosing a disease. Further, the invention relates to a method of detection of the polynucleotide of the invention. Furthermore, comprised by the present invention are a diagnostic and a pharmaceutical composition. Even more, the invention relates to uses of the polynucleotides, genes, vectors, polypeptides or antibodies of the invention. Finally, the invention relates to a diagnostic kit.
    • 本发明涉及多态性OCT1多核苷酸。 此外,本发明涉及包含本发明的多核苷酸的基因或载体以及用本发明的多核苷酸或基因进行基因工程改造的宿主细胞。 此外,本发明涉及产生分子变体多肽或其片段的方法,产生能表达分子变异多肽的细胞的方法,以及由本发明的多核苷酸或基因编码的多肽或其片段, 方法或由本发明的方法产生的细胞。 此外,本发明涉及特异性结合本发明多肽的抗体。 此外,本发明涉及转基因非人类动物。 本发明还涉及包含一种或多种上述多核苷酸,基因,载体,多肽,抗体或宿主细胞的固体支持物。 此外,鉴定多态性,鉴定和获得前药或药物或抑制剂的方法也包括在本发明中。 另外,本发明涉及生产药物组合物的方法和诊断疾病的方法。 此外,本发明涉及检测本发明多核苷酸的方法。 此外,本发明包含诊断和药物组合物。 甚至更多地,本发明涉及本发明的多核苷酸,基因,载体,多肽或抗体的用途。 最后,本发明涉及一种诊断试剂盒。
    • 6. 发明申请
    • PEPTIDES THAT DOWN REGULATE THE ACTIVITY OF PLASMA MEMBRANE TRANSPORTERS INCLUDING SODIUM-D-GLUCOSE COTRANSPORTER SGLT1
    • 降低血浆膜转运蛋白活性的肽,包括钠-D-葡萄糖酸转运蛋白SGLT1
    • WO2006105912A3
    • 2006-12-14
    • PCT/EP2006002980
    • 2006-03-31
    • UNIV WUERZBURG J MAXIMILIANSKOEPSELL HERMANNVERNALEKEN ALEXANDRA
    • KOEPSELL HERMANNVERNALEKEN ALEXANDRA
    • A61K38/08A61P3/00A61P3/08
    • A61K38/08
    • The present invention relates to the use of a regulatory protein RS1 fragment or a nucleic acid molecule encoding said regulatory protein RS1 fragment for the preparation of a pharmaceutical composition for the amelioration, prevention and/or treatment of a metabolic disease or a secondary disorder caused by a (pathological) modification of homeostasis, wherein said RS1 fragment is characterized in comprising at least 3 consecutive amino acid residues as comprised in the amino acid sequence S-D-S-D-R-I-E-P (Serine-Aspartic acid-Serine-Aspartic acid-Arginine- Isoleucine-Glutamic acid-Proline) or derivatives thereof. Furthermore, the present invention relates to a method for the amelioration, prevention and/or treatment of a metabolic disease or a secondary disorder caused by a (pathological) modification of homeostasis, said method comprising administering to a patient in need of such amelioration, prevention and/or treatment a pharmaceutically active amount of said regulatory protein RS1 fragment as defined herein or a nucleic acid molecule encoding said regulatory protein RS1 fragment. Moreover, the present invention relates to the use of said regulatory protein RS1 fragment or a nucleic acid molecule encoding said regulatory protein RS1 fragment for the preparation of food, feed and/or food supplements.
    • 本发明涉及调节蛋白RS1片段或编码所述调节蛋白RS1片段的核酸分子在制备用于改善,预防和/或治疗由以下引起的代谢疾病或继发性疾病的药物组合物中的用途: (病理学)修饰,其中所述RS1片段的特征在于包含至少3个连续的氨基酸残基,其包含在氨基酸序列SDSDRIEP(丝氨酸 - 天冬氨酸 - 丝氨酸 - 天冬氨酸 - 精氨酸 - 异亮氨酸 - 谷氨酸 - 脯氨酸 )或其衍生物。 此外,本发明涉及用于改善,预防和/或治疗由体内平衡(病理)改变引起的代谢疾病或继发性疾病的方法,所述方法包括向需要这种改善,预防 和/或治疗药学活性量的如本文所定义的所述调节蛋白RS1片段或编码所述调节蛋白RS1片段的核酸分子。 此外,本发明涉及所述调控蛋白RS1片段或编码所述调控蛋白RS1片段的核酸分子在制备食物,饲料和/或食物补充物中的用途。